Methods of making indole analogs using a rhodium-containing catalyst are described, along with methods of using the compounds to treat hyperglycemic, hyperlipidemic, or autoimmune disorders in mammals, and corresponding pharmaceutical compositions. Disclosed herein is a method of making indoles. The method comprises contacting a reactant of formula I wherein E is a protecting group, SO2-Aryl, or SO2-substituted-Aryl; and R and R2 are independently selected from the group consisting of hydrogen, halo, C1-C12-alkyl and aryl; with a rhodium(1)-containing catalyst.

The present invention relates generally to processes for producing aldehydes wherein an olefinic compound, carbon monoxide, and hydrogen are reacted in the presence of a solubilized rhodium-phosphorous complex. In one embodiment, the process comprises (a) receiving a vaporized aldehyde product stream downstream from a hydroformylation reactor, the vaporized aldehyde product stream comprising aldehydes, phosphorous ligand, and aldehyde condensation by-products; (b) contacting the vaporized aldehyde product stream with a partial condenser so as to condense the phosphorous ligand and the by-products, wherein up to 10 weight percent of the vaporized stream is condensed; (c) removing the condensed phosphorous ligand and the condensed by-products from the liquid condensation stream using a refining column; and (d) further processing the vaporized aldehydes from the separate refining column.

A method for producing an aldehyde includes the following steps (1) to (3): (1) withdrawing part or all of a reaction solution from a hydroformylation reaction zone while performing the hydroformylation reaction; (2) oxidizing by bringing the withdrawn reaction solution into contact with an oxygen-containing gas in an atmosphere having a total pressure of 0.8 MPaA or less and an oxygen partial pressure ratio of 10% or less; and (3) feeding the oxidized reaction solution to the hydroformylation reaction zone while maintaining a state in which the catalyst is dissolved or dispersed in the reaction solution.

The present disclosure relates generally to transition metal complex hydroformylation catalytic precursor compositions, to hydroformylation processes, and to processes for separating one or more heavies from a hydroformylation reaction product fluid in hydroformylation processes comprising a metal-monophosphite ligand complex catalyst.

In a process for improving a carbonylation process, iron is removed to maintain an effective Space Time Yield (STY) of the rhodium catalyst of at least 80% of the maximum STY. The process comprises carbonylating methanol in a reactor in a reaction medium comprising water, a rhodium catalyst, methyl iodide and a halide salt, separating a portion of the reaction medium in a flash vessel to form a less volatile stream and a vapor product stream comprising acetic acid, recycling a liquid stream to the reactor, wherein the liquid stream comprises a portion of the less volatile stream and wherein the liquid stream comprises iron, and removing a portion of the iron from the liquid stream to maintain an effective STY of the rhodium catalyst of at least 80% of the maximum STY.

A polymer containing a carboxyl group, a preparation method and an application thereof, a supported catalyst and a preparation method thereof and preparation methods of penem antibiotic intermediate are disclosed. The polymer has high rigidity and hardness, thus the mechanical properties of the polymer is effectively improved. Meanwhile, in the polymer, the carboxyl group is used as a main functional group, and is used as a carrier to prepare, by means of a coordination reaction between the carboxyl group and a heavy metal, a supported metal catalyst which has better connection stability between the metal and the polymer. The above two factors can improve the stability of the supported metal catalyst, such that the catalyst can be recycled without losing the catalytic activity. Meanwhile, loss of a heavy metal active ingredient and production cost can be reduced.

A homogenous process for the hydrogenation of the carboxylic acids and/or derivatives thereof in the presence of a catalyst comprising ruthenium, rhodium, iron, osmium or palladium, and an organic phosphine is described in which the hydrogenation is carried out in the presence of at least about 1% by weight water. A process for regenerating a catalyst comprising ruthenium, rhodium, iron, osmium or palladium and an organic phosphine is also described in which the regeneration is carried out in the presence of hydrogen and water.

The present invention generally relates to processes for the recovery of rhodium from a catalyst purge stream from a C6 or higher olefin hydroformylation process. In one embodiment, the process comprises (a) treating a catalyst-containing liquid purge stream from the hydroformylation process, wherein the catalyst comprises a precious metal and an organophosphorous ligand, with an oxidant in the presence of a separate liquid aqueous phase comprising a halide-free acid at a sufficient temperature to effect oxidation of a majority of the contained organophosphorous ligand, wherein the halide-free acid is a C1-C6 organic acid or phosphorous acid; (b) recovering the aqueous phase; (c) contacting the aqueous phase with a separate organic phase by mixing the two phases under a syngas atmosphere, wherein the separate organic phase comprises water-insoluble, hydrolysable organophosphorous ligand and recycled olefin from a hydroformylation process; and (d) separating the organic phase to be recycled back to a hydroformylation process.

The present disclosure relates generally to compounds, to transition metal complex hydroformylation catalytic precursor compositions, and to processes for separating one or more heavies from a hydroformylation reaction product fluid in hydroformylation processes comprising a metal-monophosphite ligand complex catalyst. In one aspect, the present disclosure relates to a compound of the following formula (I): (I) wherein R.sup.1-R.sup.5 are the same or different and are H or an alkyl moiety, wherein R.sup.6 is H, alkyl, aryl, OR7, N(R.sup.8).sub.2 and O(CH.sub.2CH.sub.2).sub.yOR.sup.8 moieties, wherein R.sup.7 is an alkyl or an aryl moiety, and wherein R.sup.8 is H, alkyl, or aryl moieties.

##STR00001##